ONCSM.E — Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Cashflow Statement
0.000.00%
Last trade - 00:00
- TRY4.10bn
- TRY4.10bn
- TRY240.51m
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1.95 | 18.7 | 71.7 | -20.8 | -79.8 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 5.11 | 5.59 | 5.22 | -2.72 | 38.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 5.97 | -10.3 | -33 | 25.1 | -40.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 16.6 | 19.4 | 51.7 | 45 | -57.3 |
Capital Expenditures | -14.7 | -16.3 | -13 | -26 | -31.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.126 | 0.078 | -24.8 | -1.05 | 9.88 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -14.8 | -16.2 | -37.8 | -27.1 | -21.7 |
Financing Cash Flow Items | -4.37 | -4.43 | -2.31 | -1.47 | 86.3 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.09 | -1.63 | -16.6 | -14.3 | 118 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3.94 | 1.55 | -2.65 | 3.63 | 39.3 |